Healthcare upgrades and initiations for Tuesday

|By:, SA News Editor

BofA upgrades Perrigo (PRGO +1.2%) to Buy from Neutral. RBC starts the shares as a Top Pick, with a $187 price target.

BofA upgrades Becton Dickinson (BDX +0.8%) to Neutral from Underperform.

RBC upgrades Johnson & Johnson (JNJ +1.6%) to Outperform from Sector Perform. Price target is $104.

Citi upgrades Varian Medical (VAR +1.6%) to Neutral from Sell.

Roth starts ANI Pharma (ANIP +9.5%) at Buy. Price target is $27.

RBC starts Teva (TEVA +0.1%) at Sector Perform. Price target is $39.

RBC starts AcelRx (ACRX +2.5%) at Outperform. Price target is $15.

RBC starts Mylan (MYL +2.3%) at Outperform. Price target is $50.

RBC starts Allergan (AGN +1.3%) at Outperform. Price target is $131.

RBC starts Impax Labs (IPXL +0.2%) at Sector Perform. Price target is $25.